CION Ameerpet
Breast Cancer Care · Hyderabad
Stage 2 Breast Cancer Treatment — Second Stage, Planned Well
Medically reviewed by Dr. Bharati Devi Gorantla, ECMO, MRCP SCE Medical Oncology (Royal Colleges UK) · Dr. Muralidhar Muddusetty, MBBS MS Surgery (AIIMS New Delhi) · Last reviewed June 2026
A Stage 2 breast cancer diagnosis can feel overwhelming — but this is a well-understood, highly treatable stage. At CION, your case goes before a full tumour board before any treatment begins. You get a clear plan, a written cost estimate, and a 45-minute consultation — not a rushed appointment.
- Tumour Board for Every Patient — medical, surgical, and radiation oncologists review your case together
- Second Stage Breast Cancer Treatment — lumpectomy, mastectomy, chemotherapy, hormone therapy, HER2-targeted therapy, radiation
- 96.9% 1-Year Survival* — vs 85.4% national average (ICMR/NCRP data)
- Indicative Cost Given in Writing — before you commit to any treatment at CION
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Understanding Your Diagnosis
What Does Stage 2 Breast Cancer Mean?
Stage 2 — also called second stage breast cancer — means the tumour has grown, or has spread to a small number of nearby lymph nodes in the armpit, but has not reached distant organs like the lungs, liver, or bones. It is divided into two groups:
Stage IIA
Tumour is 2–5 cm with no lymph node involvement, or smaller than 2 cm with up to 3 positive underarm lymph nodes. Cancer has not spread beyond the local area.
Stage IIB
Tumour is 2–5 cm with up to 3 positive lymph nodes, or larger than 5 cm with no lymph node involvement. Still considered local-regional disease with no distant spread.
What matters just as much as the stage is your tumour's receptor profile — the result of the ER, PR, HER2, and Ki-67 tests done on your biopsy. This profile is what actually guides which treatments you need. Two patients with Stage IIA breast cancer can have completely different treatment plans depending on their receptor results.
At CION, we present every Stage 2 case at a tumour board — a joint meeting of your medical oncologist, surgical oncologist, and radiation oncologist — before recommending any treatment. The plan they agree on is then explained to you in full at your 45-minute consultation.
Breast Cancer 2 Stage Treatment
How Is Stage 2 Breast Cancer Treated?
Most Stage 2 patients receive a combination of treatments. Your team at CION will recommend the right sequence based on your receptor type, tumour size, and personal circumstances.
Surgery
Lumpectomy (breast-conserving) or mastectomy — guided by tumour size, location, and your preference. Sentinel lymph node biopsy is performed during surgery to check if cancer has spread to the lymph nodes, avoiding unnecessary full lymph node removal.
Chemotherapy
Given before surgery (neoadjuvant) to shrink the tumour — or after surgery (adjuvant) to reduce the chance of cancer returning. For HER2-positive and triple-negative Stage 2 tumours, neoadjuvant chemotherapy is usually recommended first. For hormone receptor-positive tumours, a genomic test may show chemotherapy is not needed.
Hormone Therapy
For ER-positive or PR-positive Stage 2 tumours — the most common subtype. Taken as a daily tablet for 5–10 years after primary treatment. Hormone therapy works by blocking oestrogen from reaching cancer cells and is one of the most effective ways to prevent breast cancer from returning after treatment.
HER2-Targeted Therapy
For HER2-positive Stage 2 breast cancer — one of the most responsive subtypes to treatment. HER2-targeted antibody medicines given alongside chemotherapy have significantly improved outcomes for this subtype. Given for approximately one year after surgery. Many patients with HER2-positive disease achieve a strong response to neoadjuvant treatment before surgery — your oncologist will explain what this means for your specific case.
Radiation Therapy
Recommended after lumpectomy for all Stage 2 patients, and after mastectomy when lymph nodes were found to be positive. Modern techniques precisely target the breast area while protecting the heart and lungs. Radiation significantly reduces the chance of the cancer returning locally after surgery.
Allied & Supportive Care
Nutritional support to maintain strength during chemotherapy; psychological support for managing anxiety and treatment-related stress; physiotherapy for shoulder and arm movement after surgery; fertility preservation counselling for women of childbearing age who wish to preserve their options before chemotherapy.
Outcomes at CION
CION vs National 1-Year Survival — Breast Cancer
The difference in outcomes comes from one thing: a full multi-modal team working to a plan — not one doctor working alone.
*1-year overall survival, all stages combined · Source: ICMR/NCRP National Cancer Registry Programme · CION internal outcome registry
These are all-stage figures. Stage 2 outcomes are generally more favourable than all-stage averages. Individual outcomes depend on receptor profile, treatment completion, and overall health. These numbers are shared to give you honest context — not as a guarantee.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Your Second Stage Breast Cancer Treatment Plan Starts Here
17 super-specialist oncologists. A tumour board for every case. A written plan before any treatment begins. You deserve this level of care.
From Diagnosis to Treatment Plan
How We Confirm Your Stage and Plan Treatment
Before recommending any treatment, we need a complete picture of your cancer. Here is the exact process at CION — from your first appointment to your treatment plan.
Core Needle Biopsy — Confirming Cancer and Receptor Type
If a lump has been found on imaging or clinical examination, a core needle biopsy removes a small tissue sample under local anaesthesia. The lab tests it for three receptor markers — oestrogen receptor (ER), progesterone receptor (PR), and HER2 protein — plus Ki-67 (a measure of how fast cells are dividing). This result, not the stage alone, determines your treatment pathway. If you have had a biopsy elsewhere, we will review the slides and receptor results ourselves before finalising your plan.
Breast MRI and Axillary Ultrasound — Mapping the Full Extent
Contrast-enhanced MRI of the breast gives the most accurate measurement of tumour size and checks for additional areas of disease in the same breast or the other breast. An ultrasound of the armpit (axilla) looks at the lymph nodes. If any lymph nodes appear abnormal on ultrasound, a fine needle aspiration (FNA) is done to confirm whether cancer cells are present — this changes the staging and affects the treatment plan.
PET-CT Scan — Ruling Out Spread to Distant Organs
A whole-body PET-CT scan checks that the cancer has not spread to the lungs, liver, bones, or other distant organs — which would change the staging to Stage IV. At CION, this scan is available same-day at five Hyderabad locations, with an expert-reviewed report the same afternoon. Confirming Stage II (and not Stage III or IV) is essential before planning surgery or recommending neoadjuvant chemotherapy.
Tumour Board Meeting — One Plan, Agreed by Your Whole Team
Your biopsy results, imaging, and clinical findings are presented at a multi-disciplinary tumour board attended by your medical oncologist, surgical oncologist, and radiation oncologist together. They agree on the recommended treatment sequence and document it. You receive a written summary of this plan at your consultation. No single doctor is making decisions alone about your care — this is the CION standard for every patient.
Your 45-Minute Consultation — Understanding Your Plan
At your consultation, your oncologist walks through the plan in plain language — what each treatment is, why it is recommended in your specific case, the sequence and timeline, possible side effects, and all costs in writing. You have 45 minutes with no rushing. Questions are welcomed. You do not need to decide anything at the consultation — take the plan home, discuss it with your family, and come back when you are ready to start.
Stage 2 Breast Cancer Treatment Cost in India
Indicative Treatment Costs — Hyderabad
These are indicative ranges only. Your actual cost depends on your receptor type, treatment sequence, and recovery. CION provides a written cost estimate after your first consultation — before you commit to anything.
| Treatment Component | Indicative Cost Range | Notes |
|---|---|---|
| Lumpectomy (breast-conserving surgery) | ₹80,000 – ₹2,50,000 | Includes sentinel lymph node biopsy; day or 1-night admission typically |
| Mastectomy (full breast removal) | ₹1,50,000 – ₹3,50,000 | Modified radical mastectomy with axillary node dissection if needed |
| Chemotherapy (full course) | ₹1,50,000 – ₹5,00,000 | Typically 4–8 cycles; cost depends on regimen category and cycle count |
| HER2-targeted therapy (full course) | ₹3,00,000 – ₹12,00,000 | For HER2-positive tumours; 17–18 doses over approximately one year; biosimilar options available |
| Radiation therapy (full course) | ₹1,20,000 – ₹2,50,000 | After lumpectomy or post-mastectomy radiation; 15–25 sessions typically |
| Hormone therapy (per year) | ₹5,000 – ₹60,000 | For ER/PR-positive; generic tablets available; taken for 5–10 years |
| Whole-body PET-CT (staging) | ₹9,999 – ₹14,950 | Analog or digital; same-day report at CION Hyderabad centres |
| Genomic risk testing | ₹40,000 – ₹1,00,000 | For ER+/HER2- patients only; may eliminate need for chemotherapy |
Insurance & government coverage: Stage 2 breast cancer treatment is covered (fully or partially) under CGHS, ECHS, Aarogyasri, EHS, and most private health insurance policies. CION's billing team will check your coverage before treatment begins. EMI options are available for out-of-pocket costs. Ask us about up to 50% discount on diagnostics for eligible patients.
Why Choose CION
Why Patients Choose CION for Stage 2 Breast Cancer Treatment
150+ years combined oncology experience. 17 super-specialist oncologists. 35+ centres. Every case reviewed by a full tumour board.
Tumour Board for Every Stage 2 Patient — Not One Doctor's Opinion
At most centres, the first doctor you see makes the treatment recommendation alone. At CION, your case is presented at a joint meeting of a medical oncologist, surgical oncologist, and radiation oncologist before any treatment is recommended. These three specialists look at your biopsy receptor results, imaging, and clinical picture together and agree on the most appropriate sequence. You receive a written summary of their agreed plan. This multi-disciplinary approach is the international standard of care — and it is what CION delivers for every patient, not just complex cases.
45-Minute Consultations — You Leave with Answers, Not More Confusion
A Stage 2 breast cancer consultation involves a lot of information: receptor results, staging, surgery choices, chemotherapy sequences, fertility considerations, costs. CION allocates 45 minutes to every new patient consultation — time to go through the plan, answer every question you and your family have, and explain costs in writing. Most oncology appointments are 10–15 minutes. 45 minutes reflects the standard of care that you deserve at this moment in your life. You do not have to decide anything at the consultation. Take the plan home, think it through, and come back when you are ready.
Transparent Written Costs — You Know the Full Cost Before Treatment Starts
CION provides a written indicative cost estimate for the full planned treatment course before you commit to starting treatment. This includes surgery, chemotherapy cycles, radiation sessions, and hormone therapy — itemised so you can see exactly where costs are coming from. You will not receive a surprise bill mid-treatment. CION's billing team will also check your insurance or government scheme coverage (CGHS, ECHS, Aarogyasri, EHS) before treatment begins. EMI options are available. Decisions about your health should be made on medical grounds — not on financial uncertainty.
Breast-Conserving Surgery First — We Recommend Mastectomy Only When It Is Genuinely Indicated
Many Stage 2 patients are told they need mastectomy without a full discussion of whether lumpectomy plus radiation is an equally effective option for their tumour size and location. Decades of clinical evidence show that for eligible patients, lumpectomy followed by radiation achieves the same long-term survival as mastectomy. CION's surgical oncologists assess every Stage 2 patient's eligibility for breast-conserving surgery before recommending mastectomy. For larger Stage IIB tumours, neoadjuvant chemotherapy to shrink the tumour first can convert some patients who initially need mastectomy into lumpectomy candidates. The choice is always made together with you.
No Unnecessary Tests — Only What Your Treatment Plan Actually Requires
If you have already had a biopsy and receptor tests at another centre, CION will review those results. We will only repeat tests if there is a clinical reason to — for example, if the biopsy report is incomplete, if receptor results appear inconsistent with your clinical picture, or if a different tumour site needs to be sampled. Repeating tests for their own sake costs you money, causes anxiety, and delays the start of treatment. CION's principle is: decisions for healing, not billing. This applies to diagnostics just as much as to treatment choices.
Woman-Headed Organisation — Built Around the Needs of Women with Breast Cancer
CION Cancer Clinics is a woman-headed organisation — a fact that shapes how care is delivered for breast cancer patients. Consultations are conducted with privacy and sensitivity. Discussions about fertility, body image, and reconstruction are treated as standard parts of the treatment planning conversation — not add-ons you have to raise yourself. Female support staff are available throughout your treatment. This does not change the clinical rigour of your treatment plan — it changes how you feel walking into a consultation room when you are already carrying a difficult diagnosis.
Talk to a Specialist
Ready to Start Your Second Stage Breast Cancer Treatment?
Share your details and a CION specialist will call you within 2 hours during clinic hours.
15,000+ Patients Treated
Hear From Patients Who Walked This Journey With Us
A Stage 2 diagnosis is frightening. The patients below were in your position. Their experience at CION is the best evidence we can offer.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Stage 2 Breast Cancer Treatment — Frequently Asked Questions
What is Stage 2 breast cancer?
Stage 2 breast cancer — also called second stage breast cancer — means the cancer is locally present in the breast or nearby lymph nodes but has not spread to distant organs. It is divided into Stage IIA (tumour 2–5 cm with no lymph node involvement, or tumour under 2 cm with up to 3 positive axillary nodes) and Stage IIB (tumour 2–5 cm with up to 3 positive nodes, or tumour over 5 cm with no node involvement). Stage II is considered an early-to-intermediate stage. With a full course of planned treatment, outcomes are very good. The exact treatment plan depends on the tumour's receptor profile — ER, PR, HER2, and Ki-67 — not on the stage alone.
What are the treatment options for Stage 2 breast cancer?
Second stage breast cancer treatment typically combines two or more of the following: Surgery — either breast-conserving surgery (lumpectomy) or mastectomy, guided by tumour size and patient preference; Chemotherapy — given either before surgery (neoadjuvant, to shrink the tumour) or after surgery (adjuvant, to reduce recurrence risk); Hormone therapy — for ER or PR-positive cancers, taken as tablets for 5–10 years after primary treatment; HER2-targeted therapy — for HER2-positive cancers, given alongside chemotherapy; Radiation therapy — after lumpectomy for all patients, or after mastectomy when lymph nodes were involved. Your tumour board at CION will review your biopsy results and imaging and present a personalised plan at your consultation.
Is breast-conserving surgery (lumpectomy) possible at Stage 2?
Yes — for many Stage 2 patients, lumpectomy followed by radiation therapy is equally effective as mastectomy and is the preferred option when the tumour-to-breast-size ratio is favourable. For larger Stage IIB tumours, neoadjuvant chemotherapy can shrink the tumour first, making lumpectomy possible for women who might otherwise need mastectomy. The choice between lumpectomy and mastectomy is made in a shared conversation between the patient and surgical oncologist, taking into account tumour size, location, breast size, BRCA status, and the patient's own priorities. CION's surgical oncologists will discuss both options clearly so you can make an informed choice.
What is the cost of Stage 2 breast cancer treatment in India?
Stage 2 breast cancer treatment cost in India varies based on receptor type, treatment sequence, and facilities. As an indicative range: surgery (lumpectomy) ₹80,000–₹2,50,000; mastectomy ₹1,50,000–₹3,50,000; chemotherapy (full course) ₹1,50,000–₹5,00,000; radiation therapy ₹1,20,000–₹2,50,000; hormone therapy (5–10 years) ₹5,000–₹60,000 per year for generics. HER2-positive treatment adds targeted therapy costs. These are indicative figures only — your actual cost depends on your receptor profile and treatment plan. CION provides a written cost estimate after your first consultation. Treatment may be partially or fully covered under CGHS, ECHS, Aarogyasri, EHS, or your private health insurance. EMI options are available.
Do I need chemotherapy for Stage 2 breast cancer?
Not all Stage 2 patients need chemotherapy — it depends on your receptor profile and other tumour features. For hormone receptor-positive (ER/PR-positive), HER2-negative Stage II breast cancer, a genomic test on the biopsy tissue can identify patients who are at very low risk of recurrence and are unlikely to benefit from chemotherapy — allowing them to safely skip it and proceed directly to hormone therapy. For HER2-positive Stage II breast cancer, chemotherapy given alongside HER2-targeted therapy is standard care. For triple-negative Stage II breast cancer, chemotherapy is recommended and is highly effective. Your oncologist will explain the evidence for and against chemotherapy in your specific case — the decision is always made together with you.
How long does Stage 2 breast cancer treatment take?
The total treatment period for second stage breast cancer typically spans 6–12 months for the active treatment phase, plus several years of maintenance therapy. If neoadjuvant chemotherapy is recommended before surgery, it runs for approximately 4–6 months. Surgery follows, and recovery typically takes 2–6 weeks. Radiation therapy, if needed, runs for 3–6 weeks. Hormone therapy for ER-positive cancers continues for 5–10 years as a daily tablet with minimal day-to-day impact. HER2-targeted therapy continues for approximately one year after chemotherapy. CION schedules all these appointments and coordinates your team so you always know what is happening next.
You Deserve a Clear Plan. Get One Today.
A second stage breast cancer diagnosis is serious — but it is a well-treatable stage. The most important step is starting treatment with the right team and the right plan. Book your free consultation at CION.
*1-year overall survival rate. Source: ICMR/NCRP Cancer Registry; CION internal outcome registry. Individual outcomes vary. These figures are for informational context only and do not constitute a guarantee of any treatment result.